532523:BOM
Biocon Ltd
₹ 350.00
arrow_downward
-0.43%(-1.50) 1D
10-р сарын 16, 15:30:00 (GMT+5:30) · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 532523...
Open
₹ 352.95
High
₹ 352.95
Low
₹ 348.10
Mkt. cap
568.79Т
Avg. vol.
692.61 мян
Volume
668.34 мян
Dividend
0.14%
Quarterly dividend
₹ 0.13
Ex-dividend date
2026 оны 7-р сарын 3
P/E ratio
103.62
52-wk high
₹ 447.00
52-wk low
₹ 337.95
EPS
₹ 3.38
Shares outstanding
600.00 сая
No. of employees
16 мян
Open
₹ 352.95
High
₹ 352.95
Low
₹ 348.10
Mkt. cap
568.79Т
Avg. vol.
692.61 мян
Volume
668.34 мян
Dividend
0.14%
Quarterly dividend
₹ 0.13
Ex-dividend date
2026 оны 7-р сарын 3
P/E ratio
103.62
52-wk high
₹ 447.00
52-wk low
₹ 337.95
EPS
₹ 3.38
Shares outstanding
600.00 сая
No. of employees
16 мян
News stories
From web sources and news partners
Dalal Street Investment Journal
·
2 өдрийн өмнө
Biocon settles Genentech disputes, secures 2027 EU and 2028 US launch window for Pebrilzo
HDFC Sky
·
2 өдрийн өмнө
Biocon Secures Pebrilzo Launch Dates; Shares Fall 0.94%
TipRanks
·
2 өдрийн өмнө
Biocon Secures Global Deal with Genentech to Launch Pebrilzo Biosimilar
Profile
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
About Biocon Ltd
CEOShreehas P Tambe
Employees16.4 мян
Founded1978 оны 11-р сарын 29
HeadquartersБангалор, Карнатака, Энэтхэг
Sector-
Websitebiocon.com